The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia

H Jansen, I Berkman-Planken, N Hoogerbrugge, HMG Princen, MV Huisman, MA van de Ree, RP (Ronald) Stolk, FV van Venrooij, JD Banga, GM Dallinga-Thie

Research output: Contribution to journalArticleAcademicpeer-review

131 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1335-1341
Number of pages7
JournalDiabetes Care
Volume24
Publication statusPublished - 2001

Cite this